Evidence map›Paper›PMID 31455392›Full record

ArticleJournal of translational medicine2019

Perrault syndrome with neurological features in a compound heterozygote for two TWNK mutations: overlap of TWNK-related recessive disorders.

María Domínguez-Ruiz, Alberto García-Martínez, Marc Corral-Juan, Ángel I Pérez-Álvarez, Ana M Plasencia, Manuela Villamar, Miguel A Moreno-Pelayo, Antoni Matilla-Dueñas, Manuel Menéndez-González, Ignacio Del Castillo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The First HeterozygousBiomolecules · 2025
    Article
  5. A Case Report of Auditory Neuropathy Due to TWNK Gene Mutations.The journal of international advanced otology · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. A Novel Missense Mutation inPharmacogenomics and personalized medicine · 2022
    Article
  16. Article
  17. Therapy Prospects for Mitochondrial DNA Maintenance Disorders.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

María Domínguez-RuizServicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS, Carretera de Colmenar km 9.100, 28034, Madrid, Spain.
Alberto García-MartínezDepartment of Neurology, Servicio de Neurología, Hospital Universitario Central de Asturias, Avenida Roma sn, 33011, Oviedo, Spain.
Marc Corral-JuanFunctional and Translational Neurogenetics Unit, Department of Neuroscience, Health Sciences Research Institute Germans Trias i Pujol (IGTP), Universitat Autónoma de Barcelona, Can Ruti Campus, Badalona, Barcelona, Spain.
Ángel I Pérez-ÁlvarezDepartment of Neurology, Servicio de Neurología, Hospital Universitario Central de Asturias, Avenida Roma sn, 33011, Oviedo, Spain.
Ana M PlasenciaServicio de Pediatría, Hospital Universitario Central de Asturias, Oviedo, Spain.
Manuela VillamarServicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS, Carretera de Colmenar km 9.100, 28034, Madrid, Spain.
Miguel A Moreno-PelayoServicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS, Carretera de Colmenar km 9.100, 28034, Madrid, Spain.
Antoni Matilla-DueñasFunctional and Translational Neurogenetics Unit, Department of Neuroscience, Health Sciences Research Institute Germans Trias i Pujol (IGTP), Universitat Autónoma de Barcelona, Can Ruti Campus, Badalona, Barcelona, Spain.
Manuel Menéndez-GonzálezDepartment of Neurology, Servicio de Neurología, Hospital Universitario Central de Asturias, Avenida Roma sn, 33011, Oviedo, Spain. menendezgmanuel@uniovi.es.
Ignacio Del CastilloServicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS, Carretera de Colmenar km 9.100, 28034, Madrid, Spain. ignacio.castillo@salud.madrid.org.ORCID 0000-0003-1188-3665
Centre for Biomedical Network Research on Rare Diseases · ESHospital Universitario Central de Asturias · ESUniversitat Autònoma de Barcelona · ES

Funding

PREVENTING YOUTHFUL DRUG ABUSE: A LONGITUDINAL STUDYR01DA003721 · NIDA · UNIVERSITY OF WASHINGTON · PI HAWKINS, J DAVID · 1985 to 1992
–
6 · The paper itself

Abstract

backgroundPerrault syndrome is a rare autosomal recessive disorder that is characterized by the association of sensorineural hearing impairment and ovarian dysgenesis in females, whereas males have only hearing impairment. In some cases, patients present with a diversity of neurological signs. To date, mutations in six genes are known to cause Perrault syndrome, but they do not explain all clinically-diagnosed cases. In addition, the number of reported cases and the spectra of mutations are still small to establish conclusive genotype-phenotype correlations.

methodsAffected siblings from family SH19, who presented with features that were suggestive of Perrault syndrome, were subjected to audiological, neurological and gynecological examination. The genetic study included genotyping and haplotype analysis for microsatellite markers close to the genes involved in Perrault syndrome, whole-exome sequencing, and Sanger sequencing of the coding region of the TWNK gene.

resultsThree siblings from family SH19 shared similar clinical features: childhood-onset bilateral sensorineural hearing impairment, which progressed to profound deafness in the second decade of life; neurological signs (spinocerebellar ataxia, polyneuropathy), with onset in the fourth decade of life in the two females and at age 20 years in the male; gonadal dysfunction with early cessation of menses in the two females. The genetic study revealed two compound heterozygous pathogenic mutations in the TWNK gene in the three affected subjects: c.85C>T (p.Arg29*), previously reported in a case of hepatocerebral syndrome; and a novel missense mutation, c.1886C>T (p.Ser629Phe). Mutations segregated in the family according to an autosomal recessive inheritance pattern.

conclusionsOur results further illustrate the utility of genetic testing as a tool to confirm a tentative clinical diagnosis of Perrault syndrome. Studies on genotype-phenotype correlation from the hitherto reported cases indicate that patients with Perrault syndrome caused by TWNK mutations will manifest neurological signs in adulthood. Molecular and clinical characterization of novel cases of recessive disorders caused by TWNK mutations is strongly needed to get further insight into the genotype-phenotype correlations of a phenotypic continuum encompassing Perrault syndrome, infantile-onset spinocerebellar ataxia, and hepatocerebral syndrome.

Indexed as

Genes, RecessiveAdolescentAdultAmino Acid SequenceBase SequenceChild, PreschoolDNA HelicasesExonsFemaleGonadal Dysgenesis, 46,XXHearing Loss, SensorineuralHeterozygoteHumansIntronsMagnetic Resonance ImagingMaleDNA HelicasesMitochondrial ProteinsTWNK protein, humanAtaxiaHearing impairmentMitochondrial DNA helicasePerrault syndromePolyneuropathyPremature ovarian failureTWNK

Identifiers

PMID31455392
PMCPMC6712801
OpenAlexW2970791578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.